As lead of the Computational Biology Group at the Genome Center, Dr. Glasscock led a team of scientists to characterize and publish key NIH funded sequencing projects. Dr. Glasscock left his faculty position in the department of genetics and part of the Genome Center’s Technology Development Group to found Cofactor Genomics.

Spent 8 years in the Technology Development Group at The Genome Institute. In this role at Washington University, he was instrumental in the design and development of molecular tools for interrogating and characterizing the structure and sequence of DNA and RNA.

Dr. David Messina has spent the last 20 years working in computational biology and genetics. He worked on the Human Genome Project at Washington University in Saint Louis, mapped disease genes at the University of Chicago, and earned his PhD in computational biology in Stockholm, Sweden. As COO at Cofactor Genomics, he oversees daily operations and leads regulatory strategy.

Board Certified Clinical Diagnostic Pathologist – Co-directs clinical assay development at the Washington University -Member of the Clinical Laboratory Standards Institute (CLSI) for sequencing-based clinical diagnostics – Trains fellows and residents in molecular diagnostics – Informatics – Molecular Oncology

Board Certified Clinical Diagnostic Pathologist – Faculty, College of American Pathologists (CAP) – Biochemist – HOX gene regulation – Maynard Olsen Lab – NextGen Sequencing Assay Validation – FFPE tissues